- Original Articles
- Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea
-
Hui Xing Tan, Desmond Chun Hwee Teo, Dongyun Lee, Chungsoo Kim, Jing Wei Neo, Cynthia Sung, Haroun Chahed, Pei San Ang, Doreen Su Yin Tan, Rae Woong Park, Sreemanee Raaj Dorajoo
-
Healthc Inform Res. 2022;28(2):112-122. Published online April 30, 2022
-
-
Full text PubReader ePub PDF Supplementary Material
|